Innokeys was founded in 2012 by two senior professionals in pharmaceutical Indutries, Johannes Setijono and Rikrik Ilyas. 

Innokeys Vision and Mission. 
Innokeys’ mission is to provide value-added innovations in biopharmaceuticals to become a global player with significant contributions in fulfilling unmet medical needs.

Our values. 
We adopt innovative ways of thinking and doing things for a sustainable growth. We are agile to overcome various uncertainties and we always strive for excellence.

Product Website

www.nimotuzumab.com
www.theracim.com

Websites of Licensor:

CIMAB
http://www.cimab-sa.com

 

Websites of Licencees

Daiichi Sankyo (Japan)
www.daiichisankyo.com

 

Innogene Kalbiotech (Asean, Taiwan, South Africa, Nigeria, Congo)
http://www.innogene-kalbiotech.com

 

innokeys_logoInnokeys Pte Ltd (Australia, Canada, USA)
http://www.innokeys.com/

 

Screen Shot 2013-12-11 at 4.28.57 pmKuhnil Pharmaceuticals (Korea)
http://www.kuhnil.com/english/sub_01/index2.htm

 

medisonMedison Pharma (Israel)
http://www.medison.co.il

 

Oncoscience AG (Europe, Russia)
http://www.oncoscience-ag.de/de/index.htm

 

Tearai Biofarma (New Zealand)
www.tearaibiofarma.co.nz

Innokeys Pte Ltd

Org chart

Teams

Offices